iHuman Inc.
IH · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 0.00 | 0.19 | 0.79 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -20.98 | -43.77 | -65.68 | -23.21 |
| Quality | ||||
| ROIC | 1.85% | 2.03% | 1.49% | 1.95% |
| Gross Margin | 67.82% | 68.32% | 67.23% | 68.45% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -4.66% | -3.79% | -2.19% | -0.79% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -30.42 | -51.16 | -74.30 | -31.37 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.12 | 3.52 | 3.25 | 4.47 |
| Cash Conversion Cycle | 25.22 | 18.77 | 12.94 | 15.16 |